What is the equivalent dose of hydrocodone for a patient taking MS Contin (morphine sulfate) 15mg Extended Release (XR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

MS Contin 15mg XR to Hydrocodone Conversion

Based on NCCN guidelines, hydrocodone is approximately equipotent with oral morphine (1:1 ratio), so MS Contin 15mg XR converts to approximately 15mg of hydrocodone daily, which would typically be dosed as hydrocodone 5mg three times daily or 7.5mg twice daily. 1

Conversion Calculation

  • The NCCN Clinical Practice Guidelines state that hydrocodone may be approximately equipotent with oral morphine, though this equivalence data is not fully substantiated. 1
  • MS Contin 15mg XR provides 15mg of morphine over 24 hours 2, 3
  • Using the 1:1 morphine-to-hydrocodone conversion ratio, this equals approximately 15mg of hydrocodone daily 1

Practical Dosing Recommendations

  • Hydrocodone is available only in immediate-release formulations combined with acetaminophen or ibuprofen, requiring multiple daily doses. 1
  • Typical dosing options include:
    • Hydrocodone 5mg/acetaminophen 325mg: one tablet three times daily 1
    • Hydrocodone 7.5mg/acetaminophen 325mg: one tablet twice daily 1
  • Hydrocodone ER preparations exist but are less commonly used 1

Critical Safety Considerations

  • When rotating opioids, reduce the calculated equivalent dose by 25-50% to account for incomplete cross-tolerance and individual pharmacokinetic variability. 4
  • This means starting with hydrocodone 7.5-11mg daily (rather than the full 15mg equivalent) would be safer 4
  • The CDC explicitly warns against using calculated morphine milligram equivalents (MME) directly for conversions without dose reduction. 4

Important Clinical Caveats

  • Hydrocodone should be used with caution in patients with fluctuating renal function due to potential accumulation of renally cleared metabolites that may cause neurologic toxicity. 1
  • Clinical experience suggests hydrocodone is best used as a mild, initial-use opioid, and effective doses may vary significantly between patients 1
  • Reassessment within 1-4 days is necessary to adjust dosing based on pain control and adverse effects. 4
  • Provide immediate-release opioid for breakthrough pain during the conversion period 4

Alternative Consideration

  • If extended-release formulation is preferred, consider converting to a different long-acting opioid (such as oxycodone ER) rather than hydrocodone, as hydrocodone IR formulations require more frequent dosing 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.